• 15.01.2020 – 15:00

  Saba Software

  Atlas Hotels Selects Saba to Enable Unified Talent Strategy

  Bracknell, United Kingdom (ots/PRNewswire) - Furthering mission for exceptional guest experiences with an integrated, people-centric approach to recruiting and learning - Saba Software, a leading global provider of personalised talent experience solutions, today announced that award-winning UK hotel brand operator, Atlas Hotels, has selected Saba's recruiting and learning offerings to attract, hire and onboard new talent, ...

  more

• 17.12.2019 – 12:00

  Brenntag AG

  Brenntag strengthens position in the UK by acquiring specialty and industrial chemical company Tan International

  Dear all, Please find attached the press release of Brenntag on the acquisition of the British specialty and industrial chemical company Tan International. For further information please see the press release below. If you have ...

  more

  Website Brenntag

• 12.12.2019 – 18:32

  Talisker Whisky

  To support the sponsorship and mark the moment, Talisker hosted a series of events ahead of the race including a Parley Ocean School for rowers, and a gathering of like-minded outdoor adventurers, explorers, rowers and ocean enthusiasts including Brit...

  San Sebastián De La Gomera, Spain (ots/PRNewswire) - - The world's toughest rowing race - The Talisker Whisky Atlantic Challenge - returns for 2019 - This will be the biggest fleet in race history as well as the highest number of female participants to ever compete - Over 100 rowers from around the world will ...

  more

• 11.12.2019 – 08:40

  Institute for Advanced Sustainability Studies e.V. (IASS)

  

  Recommendations for Responding to the Fridays for Future Movement

  more

• 27.11.2019 – 11:53

  Aston Martin Lagonda of Europe GmbH

  

  Aston Martin partners with Bowmore on exclusive limited-edition whisky bottlings and innovative lifestyle experiences

  more

  Aston Martin Pressroom

  One document

• 20.11.2019 – 10:59

  INFOSYS

  Infosys Receives Five Awards at the DevOps Industry Awards 2019

  Bengaluru, India (ots/PRNewswire) - Infosys (NYSE: INFY), a global leader in next-generation digital services and consulting, has been recognized with five awards at the DevOps Industry Awards, 2019.The DevOps Industry Awards recognize organizations and individuals who have demonstrated noteworthy achievements for integrating and adopting DevOps practices. This is the third time in a row that Infosys has been awarded at ...

  more

• 24.09.2019 – 14:58

  Pentahotels

  

  2

  Penta Hotels takes part in World Cleanup Day to support their local communities in cleaning up neighbourhoods

  more

• 11.09.2019 – 13:41

  PLÜCOM e.K.

  

  2

  Global Renewables Shipbrokers secures largest procurement contract for offshore wind farm in Taiwan since company establishment

  more

• 26.11.2018 – 10:01

  Kyowa Kirin International PLC

  Kyowa Kirin Announces POTELIGEO® Receives Marketing Authorisation in Europe for the Treatment of Mycosis Fungoides and Sézary Syndrome

  Tokyo (ots/PRNewswire) - POTELIGEO will be the first biologic agent targeting CCR4 to be available for patients in Europe. Kyowa Hakko Kirin Co., Ltd., (Kyowa Kirin) announces today that it has received a European Commission decision granting a marketing authorisation to POTELIGEO® (Generic name: mogamulizumab), a ...

  more

• 19.11.2018 – 18:11

  Jacobs University Bremen

  

  6

  Innovative concepts sought: International experts discussed the digitization in higher education at Jacobs University

  more

• 28.09.2018 – 11:39

  Kyowa Kirin International PLC

  Kyowa Kirin Presents Data at EORTC-Cutaneous Lymphoma Task Force Meeting Showing Significantly Improved Quality of Life for Patients With Mycosis Fungoides (MF) and Sézary Syndrome (SS) on Mogamulizumab

  Tokyo (ots/PRNewswire) - First oral presentation of Quality of Life data from the phase III trial (MAVORIC), the largest randomised trial in MF and SS - the two most common types of Cutaneous T Cell Lymphoma[1] Kyowa Hakko Kirin Co., Ltd., (Kyowa Kirin) announces that Quality of Life (QoL) data from the pivotal ...

  more

• 08.08.2018 – 18:40

  Kyowa Kirin International PLC

  Kyowa Kirin Announces FDA Approval of Poteligeo® (mogamulizumab-kpkc) for the Treatment of Mycosis Fungoides and Sézary Syndrome

  Tokyo (ots/PRNewswire) - - Poteligeo has been approved for the treatment of the two most common types of Cutaneous T-cell lymphoma (CTCL) in previously treated patients based on data showing improved progression-free survival (PFS) and overall response rate (ORR) when compared to vorinostat. - FDA approval was based ...

  more